High-Grade Endometrial Cancer: Molecular Subtypes, Current Challenges, and Treatment Options

 High-Grade Endometrial Cancer: Molecular Subtypes, Current Challenges, and Treatment Options

“`html

High-Grade Endometrial Cancer: Advancements and Challenges

Recent research has made significant progress in women’s health, but the diagnosis and treatment of high-grade endometrial cancer (EnCa) have been overlooked. Integrating molecular classification with histology and profiling for mismatch repair deficiency and HER2 overexpression can provide valuable insights for treating drug-resistant recurrent EnCa. Early phase trials have shown that combination therapy with agents having different mechanisms of action is a promising approach for treatment, regardless of EnCa subtype.

Challenges and Opportunities

  • High-grade EnCa research is not as extensive as other gynecologic and breast cancers.
  • There is a need to integrate molecular profiling and biomarker development with new treatment options to improve efficacy and safety for those with high-grade recurrent EnCa.

“`

AI Products for Business or Try Custom Development

AI Sales Bot

Welcome AI Sales Bot, your 24/7 teammate! Engaging customers in natural language across all channels and learning from your materials, it’s a step towards efficient, enriched customer interactions and sales

AI Document Assistant

Unlock insights and drive decisions with our AI Insights Suite. Indexing your documents and data, it provides smart, AI-driven decision support, enhancing your productivity and decision-making.

AI Customer Support

Upgrade your support with our AI Assistant, reducing response times and personalizing interactions by analyzing documents and past engagements. Boost your team and customer satisfaction

AI Scrum Bot

Enhance agile management with our AI Scrum Bot, it helps to organize retrospectives. It answers queries and boosts collaboration and efficiency in your scrum processes.